CytoSorbents Announces Compliance with Nasdaq Minimum Bid Price Requirement

Stock Information for Citius Pharmaceuticals Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Citius Pharmaceuticals Inc.

CytoSorbents to Present at the H.C. Wainwright 26?? Annual Global Investment Conference
CytoSorbents Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
CytoSorbents Reports Second Quarter 2024 Financial and Operational Results
CytoSorbents Appoints Peter J. Mariani Chief Financial Officer
CytoSorbents to Report Second Quarter 2024 Operating and Financial Results
CytoSorbents Unveils Newly Redesigned, Unified Company and Product Website
CytoSorbents to Present at the Inaugural American Association of Physicians of Indian Origin (AAPI) World Health Congress
CytoSorbents Secures $20 Million Credit Facility

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.